Project Grant R01AI184419
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$847K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This $653,693 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA 93.855 Allergy and Infectious Diseases Research, supports structural studies of the HIV-1 virus assembly and maturation process, as well as the mechanism of action of the capsid-targeting compound lenacapavir. Specifically, the award will fund the use of cryo-electron microscopy and tomography techniques to examine the molecular details of the immature and mature HIV capsid...
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the dynamics and evolution of HIV Gag and GagPol processing. The $752,745 award aims to use molecular dynamics simulations, single-molecule FRET imaging, and cryo-electron tomography to probe the structure and dynamics of Gag and GagPol that enable ordered processing by the viral...
This federal Project Grant award of $696,828, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural basis of HIV-1 cap hypermethylation and its linkage to viral post-transcriptional control and modulation of host innate immune signaling. Key objectives include elucidating the role of the HIV-1 Rev/RRE regulatory system in cap hypermethylation, and how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $617,376 to Emory University to conduct research on the activation and maturation of the HIV-1 protease enzyme. The objective is to elucidate the timing and regulation of protease autoactivation, which is critical for the formation of mature, infectious HIV-1 particles. The research will utilize advanced imaging...
The federal Project Grant award R21AI185846, totaling $173,487.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports scientific research focused on developing a novel treatment for HIV infection through the targeted degradation of the HIV integrase protein. This research aims to address the growing prevalence of antiretroviral drug resistance, which has become a...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $220,224 to the University of Chicago for computational investigations of HIV-1 assembly, maturation, and uncoating processes. The research aims to advance the mechanistic understanding of these critical viral life cycle stages, which could aid in the design of future antiretroviral therapies that disrupt these...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is providing $176,096 to the University of Illinois to develop a computational toolkit for systematically dissecting protein drug resistance mechanisms in the context of HIV antivirals. The goal is to elucidate the mechanisms of HIV drug resistance and establish protocols for manipulating protein interactions and dynamics to...
This $197,366 five-year Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to advance understanding of how the human immune system naturally restricts a specific subset of HIV known as X4-tropic virus. The research study, conducted by The Washington University in Missouri, will (1) characterize the molecular mechanisms driving the immune-mediated restriction of X4-tropic viral...
This Project Grant award for $1,314,572.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research aimed at developing a cure strategy for HIV-1 using CD4-mimetic compounds (CD4MCs) and CD4-induced antibodies (CD4I Abs). The research, conducted by Yale University, leverages the recent discovery of a new class of indoline CD4MCs that display improved antiviral potency and breadth...
The federal Project Grant award F31AI189273, totaling $140,733, was made by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to mechanistically interrogate how and where retroviruses, such as HIV and the mouse mammary tumor virus (MMTV), integrate viral DNA into chromatin. The proposed work will employ novel nucleosome reconstitution and sequencing strategies, biochemical...